Previously, we observed that semaphorin 6A (SEMA6A), a single-pass transmembrane protein involved in the axonal guidance pathway14–18, was significantly downregulated in lung cancer tissues as compared to adjacent normal tissues19. This evidence concerns the gene SEMA6A and lung carcinoma.